PETROCHINA (00857) controlling shareholder's shareholding plan has been fully implemented, accumulating a total of 309 million shares held.

20:01 07/04/2026

China Petroleum Company Limited (00857) announced that the controlling shareholder of the company, China Petroleum & Natural Gas Group Limited (CNPC) and its wholly-owned subsidiary, had cumulatively increased their holdings in the company by 309 million shares through the Shanghai Stock Exchange system and the Hong Kong Stock Exchange system from April 8, 2025 to April 7, 2026. This represents 0.17% of the total share capital of the company, with a total amount of 2.801 billion RMB. The actual amount of the increase has reached the lower limit of the increase plan and the increase plan has been completed.

PETROCHINA (00857) announced that its controlling shareholder, PetroChina Natural Gas Group Co., Ltd. (PetroChina Group) and its wholly-owned subsidiaries have cumulatively increased their holdings of the company's shares through the Shanghai Stock Exchange trading system and the Hong Kong Stock Exchange system from April 8, 2025 to April 7, 2026. They have acquired a total of 309 million shares, accounting for 0.17% of the company's total share capital, with a total amount of RMB 2.801 billion. The actual amount of the share increase has reached the lower limit of the increase plan, and the share increase plan has been completed.

New stock news | Cancer early screening track welcomes heavyweight player Amyson submits application to Hong Kong Stock Exchange Core products have been approved by the National Medical Products Administration.

Triple the dose, with a monthly increase of only $50: Novo Nordisk A/S Sponsored ADR Class B (NVO.US) boosts the dose of Wegovy to compete with Eli Lilly and Company's Zepbound (LLY.US).

Nasdaq ETF changes! BlackRock, Inc. (BLK.US) and State Street (STT.US) are squeezing, and Invesco's (IVZ.US) near 20-year monopolistic position is in jeopardy.

Triple the dose, with a monthly increase of only $50: Novo Nordisk A/S Sponsored ADR Class B (NVO.US) boosts the dose of Wegovy to compete with Eli Lilly and Company's Zepbound (LLY.US).

Nasdaq ETF changes! BlackRock, Inc. (BLK.US) and State Street (STT.US) are squeezing, and Invesco's (IVZ.US) near 20-year monopolistic position is in jeopardy.